{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T20:33:00Z","timestamp":1783110780505,"version":"3.54.6"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005891","name":"State Administration of Traditional Chinese Medicine of the People's Republic of China","doi-asserted-by":"publisher","award":["2024B0254"],"award-info":[{"award-number":["2024B0254"]}],"id":[{"id":"10.13039\/501100005891","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Jiangxi Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["20252BAC200560"],"award-info":[{"award-number":["20252BAC200560"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.phymed.2025.157553","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T02:31:10Z","timestamp":1763346670000},"page":"157553","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Liquiritigenin attenuates thrombosis by inhibiting P2Y12R-mediated Src\/PLC\u03b32 signaling and cytoplasmic Ca2+ mobilization in platelets"],"prefix":"10.1016","volume":"149","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-1700-221X","authenticated-orcid":false,"given":"Linhui","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanrong","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangdi","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.phymed.2025.157553_bib0001","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.tips.2004.10.010","article-title":"The recently deorphanized GPR80 (GPR99) proposed to be the P2Y15 receptor is not a genuine P2Y receptor","volume":"26","author":"Abbracchio","year":"2005","journal-title":"Trends Pharmacol. Sci."},{"issue":"20","key":"10.1016\/j.phymed.2025.157553_bib0002","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1182\/blood-2013-03-487850","article-title":"cAMP signaling regulates platelet myosin light chain (MLC) phosphorylation and shape change through targeting the RhoA-Rho kinase-MLC phosphatase signaling pathway","volume":"122","author":"Aburima","year":"2013","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.phymed.2025.157553_bib0003","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1016\/j.jcin.2023.08.019","article-title":"Dyspnea-related ticagrelor discontinuation after percutaneous coronary intervention","volume":"16","author":"Angiolillo","year":"2023","journal-title":"JACC. Cardiovasc. Interv."},{"key":"10.1016\/j.phymed.2025.157553_bib0004","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-pathmechdis-051222-015009","article-title":"Neutrophils in physiology and pathology","volume":"19","author":"Aroca-Crevill\u00e9n","year":"2024","journal-title":"Annu Rev. Pathol."},{"issue":"23","key":"10.1016\/j.phymed.2025.157553_bib0005","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1016\/j.jacc.2020.04.031","article-title":"COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC State-of-the-art review","volume":"75","author":"Bikdeli","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"7","key":"10.1016\/j.phymed.2025.157553_bib0006","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1001\/jamacardio.2022.1292","article-title":"Efficacy and safety considerations with dose-reduced direct oral anticoagulants: a review","volume":"7","author":"Bikdeli","year":"2022","journal-title":"JAMA Cardiol."},{"issue":"5","key":"10.1016\/j.phymed.2025.157553_bib0007","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1182\/blood.V75.5.1081.1081","article-title":"Released adenosine diphosphate stabilizes thrombin-induced human platelet aggregates","volume":"75","author":"Cattaneo","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.phymed.2025.157553_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155946","article-title":"Paeoniflorin inhibits PRAS40 interaction with Raptor to activate mTORC1 to reverse excessive autophagy in airway epithelial cells for asthma","volume":"134","author":"Cheng","year":"2024","journal-title":"Phytomed.: Int. J. Phytother. Phytopharm."},{"issue":"10486","key":"10.1016\/j.phymed.2025.157553_bib0009","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/S0140-6736(25)00449-0","article-title":"Efficacy and safety of clopidogrel versus aspirin monotherapy in patients at high risk of subsequent cardiovascular event after percutaneous coronary intervention (SMART-CHOICE 3): a randomised, open-label, multicentre trial","volume":"405","author":"Choi","year":"2025","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.phymed.2025.157553_bib0010","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1253\/circj.CJ-21-0848","article-title":"Pathophysiology of coronary microvascular dysfunction","volume":"86","author":"Crea","year":"2022","journal-title":"Circ. J.: Off. J. Jpn. Circ. Soc."},{"issue":"2","key":"10.1016\/j.phymed.2025.157553_bib0011","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1152\/physiol.00020.2016","article-title":"New concepts and mechanisms of platelet activation signaling","volume":"32","author":"Estevez","year":"2017","journal-title":"Physiology"},{"issue":"Suppl 1","key":"10.1016\/j.phymed.2025.157553_bib0012","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1538-7836.2007.02482.x","article-title":"In vivo thrombus formation","volume":"5","author":"Furie","year":"2007","journal-title":"J. Thromb. Haemost.: JTH"},{"issue":"10258","key":"10.1016\/j.phymed.2025.157553_bib0013","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","year":"2020","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.phymed.2025.157553_bib0014","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/bjh.12682","article-title":"Secrets of platelet exocytosis - what do we really know about platelet secretion mechanisms?","volume":"165","author":"Golebiewska","year":"2013","journal-title":"Br. J. Haematol."},{"issue":"2","key":"10.1016\/j.phymed.2025.157553_bib0015","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1001\/jamacardio.2018.4537","article-title":"Cardiovascular risk factors associated with venous thromboembolism","volume":"4","author":"Gregson","year":"2019","journal-title":"JAMA Cardiol."},{"issue":"5","key":"10.1016\/j.phymed.2025.157553_bib0016","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1142\/S0192415X24500599","article-title":"Liquiritigenin, an active ingredient of liquorice, alleviates acute kidney injury by VKORC1-mediated ferroptosis inhibition","volume":"52","author":"Guo","year":"2024","journal-title":"Am. J. Chin. Med."},{"issue":"11","key":"10.1016\/j.phymed.2025.157553_bib0017","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.031606","article-title":"Review of the Ticagrelor trials evidence base","volume":"13","author":"Herron","year":"2024","journal-title":"J. Am. Heart. Assoc."},{"issue":"3","key":"10.1016\/j.phymed.2025.157553_bib0018","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1142\/S0192415X24500289","article-title":"A comprehensive review of licorice: the preparation, chemical composition, bioactivities and its applications","volume":"52","author":"Ji","year":"2024","journal-title":"Am. J. Chin. Med."},{"issue":"14","key":"10.1016\/j.phymed.2025.157553_bib0019","doi-asserted-by":"crossref","first-page":"8070","DOI":"10.1073\/pnas.95.14.8070","article-title":"Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation","volume":"95","author":"Jin","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"issue":"4","key":"10.1016\/j.phymed.2025.157553_bib0020","first-page":"279","article-title":"Safety of switching from a vitamin K antagonist to a non-vitamin K antagonist oral anticoagulant in frail older patients with atrial fibrillation: results of the FRAIL-AF randomized controlled trial","volume":"149","author":"Joosten","year":"2024","journal-title":"Circulation"},{"issue":"24","key":"10.1016\/j.phymed.2025.157553_bib0021","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1182\/blood.2024025476","article-title":"Procoagulant platelet activation promotes venous thrombosis","volume":"144","author":"Kaiser","year":"2024","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.phymed.2025.157553_bib0022","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/jamacardio.2024.4030","article-title":"Long-term aspirin vs clopidogrel after coronary stenting by bleeding risk and procedural complexity","volume":"10","author":"Kang","year":"2025","journal-title":"JAMA Cardiol."},{"issue":"16","key":"10.1016\/j.phymed.2025.157553_bib0023","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.23.00294","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO guideline update","volume":"41","author":"Key","year":"2023","journal-title":"J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.phymed.2025.157553_bib0024","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3109\/09537104.2010.497231","article-title":"P2Y12 receptor in platelet activation","volume":"22","author":"Kim","year":"2011","journal-title":"Platelets."},{"issue":"4","key":"10.1016\/j.phymed.2025.157553_bib0025","doi-asserted-by":"crossref","first-page":"686","DOI":"10.3892\/mmr.2021.12326","article-title":"Liquiritigenin attenuates isoprenaline\u2011induced myocardial fibrosis in mice through the TGF\u2011\u03b21\/Smad2 and AKT\/ERK signaling pathways","volume":"24","author":"Li","year":"2021","journal-title":"Mol. Med. Rep."},{"issue":"12","key":"10.1016\/j.phymed.2025.157553_bib0026","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1161\/ATVBAHA.110.207522","article-title":"Signaling during platelet adhesion and activation","volume":"30","author":"Li","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"5","key":"10.1016\/j.phymed.2025.157553_bib0027","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41573-020-0061-0","article-title":"Therapeutic strategies for thrombosis: new targets and approaches","volume":"19","author":"Mackman","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"issue":"10304","key":"10.1016\/j.phymed.2025.157553_bib0028","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","article-title":"Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants","volume":"398","year":"2021","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.phymed.2025.157553_bib0029","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.jacc.2005.01.034","article-title":"Resistance to clopidogrel: a review of the evidence","volume":"45","author":"Nguyen","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"issue":"15","key":"10.1016\/j.phymed.2025.157553_bib0030","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1182\/blood-2010-12-323204","article-title":"An important role for Akt3 in platelet activation and thrombosis","volume":"118","author":"O'Brien","year":"2011","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.phymed.2025.157553_bib0031","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1055\/s-2005-869518","article-title":"Platelet aggregation and adenosine diphosphate\/adenosine triphosphate receptors: a historical perspective","volume":"31","author":"Packham","year":"2005","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.phymed.2025.157553_bib0032","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8703627","article-title":"The role of Clopidogrel in 2020: a reappraisal","volume":"2020","author":"Patti","year":"2020","journal-title":"Cardiovasc. Ther."},{"issue":"24","key":"10.1016\/j.phymed.2025.157553_bib0033","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1016\/j.jacc.2023.10.010","article-title":"Apixaban for prevention of thromboembolism in pediatric heart disease","volume":"82","author":"Payne","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.phymed.2025.157553_bib0034","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.119.007811","article-title":"Clopidogrel Pharmacogenetics","volume":"12","author":"Pereira","year":"2019","journal-title":"Circ. Cardiovasc. Interv."},{"issue":"6","key":"10.1016\/j.phymed.2025.157553_bib0035","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/j.1538-7836.2004.00741.x","article-title":"Different G protein-coupled signaling pathways are involved in alpha granule release from human platelets","volume":"2","author":"Quinton","year":"2004","journal-title":"J. Thromb. Haemost.: JTH"},{"issue":"4","key":"10.1016\/j.phymed.2025.157553_bib0036","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1152\/physrev.2000.80.4.1291","article-title":"Structure, function, and control of phosphoinositide-specific phospholipase C","volume":"80","author":"Rebecchi","year":"2000","journal-title":"Physiol. Rev."},{"issue":"6","key":"10.1016\/j.phymed.2025.157553_bib0037","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1182\/blood-2010-02-270934","article-title":"Munc13-4 is a limiting factor in the pathway required for platelet granule release and hemostasis","volume":"116","author":"Ren","year":"2010","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.phymed.2025.157553_bib0038","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1152\/physrev.00067.2017","article-title":"Wound healing: a cellular perspective","volume":"99","author":"Rodrigues","year":"2019","journal-title":"Physiol. Rev."},{"issue":"25","key":"10.1016\/j.phymed.2025.157553_bib0039","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global Burden of cardiovascular diseases and Risk Factors, 1990-2019: update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"29","key":"10.1016\/j.phymed.2025.157553_bib0040","doi-asserted-by":"crossref","first-page":"11069","DOI":"10.1073\/pnas.0510446103","article-title":"The active metabolite of Clopidogrel disrupts P2Y12 receptor oligomers and partitions them out of lipid rafts","volume":"103","author":"Savi","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.phymed.2025.157553_bib0041","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.2147\/IJN.S235832","article-title":"Liquiritigenin-loaded submicron emulsion protects against doxorubicin-induced cardiotoxicity via antioxidant, anti-inflammatory, and anti-apoptotic activity","volume":"15","author":"Shi","year":"2020","journal-title":"Int. J. Nanomed."},{"issue":"16","key":"10.1016\/j.phymed.2025.157553_bib0042","doi-asserted-by":"crossref","first-page":"11324","DOI":"10.1021\/acs.jmedchem.3c00815","article-title":"Liquiritigenin confers liver protection by enhancing NRF2 signaling through both canonical and non-canonical signaling pathways","volume":"66","author":"Shi","year":"2023","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.phymed.2025.157553_bib0043","first-page":"476","article-title":"Personalizing antiplatelet therapy with clopidogrel","volume":"92","author":"Trenk","year":"2012","journal-title":"Clin. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.phymed.2025.157553_bib0044","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1001\/jamacardio.2024.0133","article-title":"Ticagrelor or clopidogrel monotherapy vs dual antiplatelet therapy after percutaneous coronary intervention: a systematic review and patient-level meta-analysis","volume":"9","author":"Valgimigli","year":"2024","journal-title":"JAMA Cardiol."},{"issue":"1","key":"10.1016\/j.phymed.2025.157553_bib0045","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1152\/physrev.00016.2011","article-title":"New fundamentals in hemostasis","volume":"93","author":"Versteeg","year":"2013","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.phymed.2025.157553_bib0046","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2015.6","article-title":"Venous thrombosis","volume":"1","author":"Wolberg","year":"2015","journal-title":"Nat. Rev., Dis. Primers"},{"key":"10.1016\/j.phymed.2025.157553_bib0047","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.biopha.2016.12.066","article-title":"Liquiritigenin attenuates cardiac injury induced by high fructose-feeding through fibrosis and inflammation suppression","volume":"86","author":"Xie","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.phymed.2025.157553_bib0048","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.immuni.2023.02.015","article-title":"STING activation in platelets aggravates septic thrombosis by enhancing platelet activation and granule secretion","volume":"56","author":"Yang","year":"2023","journal-title":"Immunity."},{"issue":"3","key":"10.1016\/j.phymed.2025.157553_bib0049","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1124\/pr.117.014530","article-title":"Platelet signaling and disease: targeted therapy for thrombosis and other related diseases","volume":"70","author":"Yeung","year":"2018","journal-title":"Pharmacol. Rev."},{"issue":"7498","key":"10.1016\/j.phymed.2025.157553_bib0050","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nature13288","article-title":"Agonist-bound structure of the human P2Y12 receptor","volume":"509","author":"Zhang","year":"2014","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.phymed.2025.157553_bib0051","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1002\/ptr.7528","article-title":"Liquiritigenin protects against myocardial ischemic by inhibiting oxidative stress, apoptosis, and l-type Ca2+ channels","volume":"36","author":"Zhang","year":"2022","journal-title":"Phytother. Res.: PTR"},{"issue":"15","key":"10.1016\/j.phymed.2025.157553_bib0052","doi-asserted-by":"crossref","first-page":"4524","DOI":"10.1182\/bloodadvances.2022007007","article-title":"GRK2 regulates ADP signaling in platelets via P2Y1 and P2Y12","volume":"6","author":"Zhao","year":"2022","journal-title":"Blood Adv."},{"issue":"4","key":"10.1016\/j.phymed.2025.157553_bib0053","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/jth.15625","article-title":"Galectin-9 activates platelet ITAM receptors glycoprotein VI and C-type lectin-like receptor-2","volume":"20","author":"Zhi","year":"2022","journal-title":"J. Thromb. Haemost.: JTH"},{"key":"10.1016\/j.phymed.2025.157553_bib0054","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177670","article-title":"The soluble guanylate cyclase (sGC) stimulator vericiguat inhibits platelet activation and thrombosis","volume":"999","author":"Zhou","year":"2025","journal-title":"Eur. J. Pharmacol."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711325011894?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711325011894?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T11:23:18Z","timestamp":1766661798000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711325011894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":54,"alternative-id":["S0944711325011894"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2025.157553","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liquiritigenin attenuates thrombosis by inhibiting P2Y12R-mediated Src\/PLC\u03b32 signaling and cytoplasmic Ca2+ mobilization in platelets","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2025.157553","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"157553"}}